DATATRAK International, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2018
May 07, 2018 at 10:30 am EDT
Share
DATATRAK International, Inc. announced unaudited consolidated earnings results for the first quarter ended March 31, 2018. For the quarter, the company reported revenue was $1,754,313 against $1,952,531 a year ago. Loss from operations was $111,826 against $273,652 a year ago. Net loss before tax provision was $109,725 against $315,406 a year ago. Net loss was $109,725 against $315,406 a year ago. Basic and diluted net loss per share was $0.05 against $0.18 a year ago.
Datatrak International, Inc. is a technology and services company. The Company is engaged in delivering global eClinical solutions for the clinical trials industry. The Company is focused on providing subscription and professional services. Its enterprise platforms include Decentralized Trials (including, electronic consent (e-Consent), electronic patient reported outcomes (e-PRO) and electronic clinical outcomes assessment (e-COA), electronic data capture, clinical trial management system (CTMS) and imaging and endpoint adjudication, randomization, and business intelligence. The Companyâs CTMS includes functions for site feasibility and the tracking of action items and milestones. Its imaging and endpoint adjudication is a streamline the approach for managing imaging components while reducing manual workload and errors. Its business intelligence offers solution to create, monitor, and analyze user research and providing insights that allow to optimize processes from all aspects.
DATATRAK INTERNATIONAL, INC. 
